Market Cap | 295.94M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.79M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -4.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -12.00% |
Recommedations | - | Quick Ratio | 0.23 | Shares Outstanding | 25.64M | 52W Low Chg | 39.00% |
Insider Own | 2.61% | ROA | - | Shares Float | 23.22M | Beta | - |
Inst Own | 89.16% | ROE | - | Shares Shorted/Prior | 618.35K/619.72K | Price | 9.28 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 166,791 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 338,836 | Change | -7.20% |
Social Capital Suvretta Holdings Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector. Social Capital Suvretta Holdings Corp. III was incorporated in 2021 and is based in Henderson, Nevada.